ProtoKinetix, Incorporated (PKTX)

Market Cap	2.26M +7.8%
Revenue (ttm)	n/a
Net Income	-376.17K
EPS	-0.00
Shares Out	411.63M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,962
Open	0.0063
Previous Close	0.0001
Day's Range	0.0001 - 0.0063
52-Week Range	0.0001 - 0.0124
Beta	0.76
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 2, 2026

About ProtoKinetix

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incor...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 5
• Stock Exchange: OTCMKTS
• Ticker Symbol: PKTX

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 31, 2026

Data Sources Report a data error